Cargando…

Role of Anti-Müllerian Hormone in the Pathogenesis of Polycystic Ovary Syndrome

Besides its interest for diagnosis, the finding of an elevated serum AMH level in PCOS has open major pathophysiological issues. This review addresses the three most important issues: 1- the role of AMH in the disturbed folliculogenesis of PCOS; 2- the role of AMH in the gonadotropin dysregulation o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dewailly, Didier, Barbotin, Anne-Laure, Dumont, Agathe, Catteau-Jonard, Sophie, Robin, Geoffroy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509053/ https://www.ncbi.nlm.nih.gov/pubmed/33013710 http://dx.doi.org/10.3389/fendo.2020.00641

Ejemplares similares

Role of Anti-Müllerian Hormone in pathophysiology, diagnosis and treatment of Polycystic Ovary Syndrome: a review
por: Dumont, Agathe, et al.
Publicado: (2015)

Elevated prenatal anti-Müllerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood
por: Tata, Brooke, et al.
Publicado: (2018)

Anti-Müllerian hormone serum level and other markers associated with pregnancy outcome in oocyte donation
por: Delesalle, Anne-Sophie, et al.
Publicado: (2016)

Does polycystic ovarian morphology influence the response to treatment with pulsatile GnRH in functional hypothalamic amenorrhea?
por: Dumont, Agathe, et al.
Publicado: (2016)

Müllerian Duct Anomalies and Anti-Müllerian Hormone Levels in Women With Polycystic Ovary Syndrome
por: Yang, Min, et al.
Publicado: (2023)

Polycystic ovary syndrome phenotype does not have impact on oocyte morphology
por: Uk, Audrey, et al.
Publicado: (2022)

How to Choose the Optimal Starting Dose of Clomiphene Citrate (50 or 100 mg per Day) for a First Cycle of Ovulation Induction in Anovulatory PCOS Women?
por: Huyghe, Lucie, et al.
Publicado: (2023)

Elevated Anti-Müllerian Hormone Is an Independent Risk Factor for Preterm Birth Among Patients With Overweight Polycystic Ovary Syndrome
por: Du, Mingze, et al.
Publicado: (2021)

Novel role for anti-Müllerian hormone in the regulation of GnRH neuron excitability and hormone secretion
por: Cimino, Irene, et al.
Publicado: (2016)

Contribution of serum anti-Müllerian hormone in the management of azoospermia and the prediction of testicular sperm retrieval outcomes: a study of 155 adult men
por: Benderradji, Hamza, et al.
Publicado: (2021)

OR35-04 Anti-Müllerian Hormone Variants identified in Patients with Polycystic Ovary Syndrome Affect Secretion and Immunoactivity
por: Meng, Li, et al.
Publicado: (2023)

SAT-010 Non-Classic POR Deficiency as a Cause of Menstrual Disorders & Infertility
por: Papadakis, Georgios E, et al.
Publicado: (2020)

Anti-Müllerian hormone (AMH) in the Diagnosis of Menstrual Disturbance Due to Polycystic Ovarian Syndrome
por: Abbara, Ali, et al.
Publicado: (2019)

Polycystic ovary syndrome is transmitted via a transgenerational epigenetic process
por: Mimouni, Nour El Houda, et al.
Publicado: (2021)

Could Cytochrome P450 2D6, 3A4 and 3A5 Polymorphisms Explain the Variability in Clinical Response to Clomiphene Citrate of Anovulatory PCOS Women?
por: Robin, Camille, et al.
Publicado: (2021)

Anti-Müllerian Hormone Signal Transduction involved in Müllerian Duct Regression
por: Cate, Richard L.
Publicado: (2022)

Assessment of Anti-Müllerian Hormone Level in Management of Adolescents with Polycystic Ovary Syndrome
por: Dursun, Fatma, et al.
Publicado: (2016)

The Relationship of Anti-Mullerian Hormone in Polycystic Ovary Syndrome Patients with Different Subgroups
por: Ran, Yu, et al.
Publicado: (2021)

Anti-Müllerian Hormone and Polycystic Ovary Syndrome in Women and Its Male Equivalent
por: di Clemente, Nathalie, et al.
Publicado: (2022)

The Role of Serum Anti-Mullerian Hormone Measurement in the Diagnosis of Polycystic Ovary Syndrome
por: Sivanandy, Mala S., et al.
Publicado: (2023)

SUN-021 Age-Specific Multiples of the Median Level of Serum Anti-Mullerian Hormone Is a Potential Marker for Diagnosis of Polycystic Ovary Syndrome
por: Raymond Li, Hang Wun, et al.
Publicado: (2020)

Defining Reference Ranges for Serum Anti-Müllerian Hormone on a Large Cohort of Normozoospermic Adult Men Highlights New Potential Physiological Functions of AMH on FSH Secretion and Sperm Motility
por: Benderradji, Hamza, et al.
Publicado: (2022)

High anti-Mullerian hormone level is adversely associated with cumulative live birth rates of two embryo transfers after the first initiated cycle in patients with polycystic ovary syndrome
por: Su, Nianjun, et al.
Publicado: (2023)

SAT-258 Anti-Mullerian Hormone (AMH) Levels Reflect Ovarian Follicle Count by MRI but Not Ovarian Size in Young Patients with Polycystic Ovary Syndrome
por: Pereira-Eshraghi, Camila, et al.
Publicado: (2019)

Hashimoto’s thyroiditis worsens ovaries in polycystic ovary syndrome patients compared to Anti-Müllerian hormone levels
por: Serin, Aliye Nigar, et al.
Publicado: (2021)

A case-control study about markers of stress in normal-/overweight women with polycystic ovary syndrome and in controls
por: Marschalek, Marie-Louise, et al.
Publicado: (2023)

Letter to the Editor: Serum anti-Müllerian hormone levels and phenotypes of polycystic ovary syndrome
por: Joob, Beuy, et al.
Publicado: (2013)

The Author Response: Serum anti-Müllerian hormone levels and phenotypes of polycystic ovary syndrome
por: Kim, Hye Ok
Publicado: (2013)

Anti-mullerian and androgens hormones in women with polycystic ovary syndrome undergoing IVF/ICSI
por: Swellam, Menha, et al.
Publicado: (2013)

Anti-Müllerian hormone as a predictor of polycystic ovary syndrome treated with clomiphene citrate
por: Hestiantoro, Andon, et al.
Publicado: (2016)

Salivary and serum androgens with anti-Müllerian hormone measurement for the diagnosis of polycystic ovary syndrome
por: Sathyapalan, Thozhukat, et al.
Publicado: (2018)

Threshold value of anti-Mullerian hormone for the diagnosis of polycystic ovary syndrome in Chinese women
por: Yue, Chao-Yan, et al.
Publicado: (2018)

Serum Anti-Müllerian Hormone in the Diagnosis of Polycystic Ovary Syndrome in Association with Clinical Symptoms
por: Ahmed, Nada, et al.
Publicado: (2019)

Polycystic ovary syndrome mouse model by prenatal exposure to high anti-Müllerian hormone
por: Mimouni, Nour El Houda, et al.
Publicado: (2021)

Polycystic Ovary Syndrome Phenotype D Versus Functional Hypothalamic Amenorrhea With Polycystic Ovarian Morphology: A Retrospective Study About a Frequent Differential Diagnosis
por: Beitl, Klara, et al.
Publicado: (2022)

Differentiation between polycystic ovary syndrome and polycystic ovarian morphology by means of an anti-Müllerian hormone cutoff value
por: Song, Do Kyeong, et al.
Publicado: (2017)

Elevated Anti-Müllerian Hormone Levels in Newborns of Women with Polycystic Ovary Syndrome: a Systematic Review and Meta-analysis Based on Observational Studies
por: Zhou, Siyu, et al.
Publicado: (2021)

Longitudinal Anti-Müllerian Hormone in Women with Polycystic Ovary Syndrome: An Acupuncture Randomized Clinical Trial
por: Franasiak, Jason, et al.
Publicado: (2012)

Androgen and Anti-Mullerian Hormone Concentrations at Term in Newborns and Their Mothers with and without Polycystic Ovary Syndrome
por: Kollmann, Martina, et al.
Publicado: (2019)

Abnormalities of early folliculogenesis and serum anti-Müllerian hormone in chinese patients with polycystic ovary syndrome
por: Du, Juan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lln3n8k2q7j7a4f35ottdkb51c